耐火性无形成性贫血患者罗米普洛司姆反应的预测因素:来自两项临床试验的数据
Jun Ho Jang1, Kinuko Mitani2, Yoshiaki Tomiyama3
1Department of Hematology, Sungkyunkwan University Samsung Medical Center, Seoul, Republic of Korea.
Annals of hematology
|July 1, 2025
概括
这项研究确定了罗米普洛司姆在不塑性贫血 (AA) 患者中疗效的关键预测因子,这些患者不耐免疫抑制治疗. 基线的网红细胞和血小板计数,以及诊断持续时间,预测对这种血栓形成素受体激动剂 (TPO-RA) 的反应.
科学领域:
- 血液学 血液学 血液学
- 临床试验 临床试验
- 药理学 药理学是指药理学的学科.
背景情况:
- 无形性贫血 (AA) 是一种罕见的骨髓衰竭疾病.
- 罗米普洛斯蒂姆是一种血栓形成素受体激动剂 (TPO-RA),在耐火性AA中显示出有效性.
- 在AA中TPO-RA反应的预测因素仍然未得到充分探索.
研究的目的:
- 为了确定临床和实验室预测罗米普洛司姆在耐火性AA患者的疗效.
- 分析两项临床试验 (NCT02094417,NCT02773290) 的数据,以确定这些预测因素.
主要方法:
- 来自两项临床试验的患者数据的回顾性分析,涉及66名耐火性AA患者.
- 统变逻辑回归和接收器运行特征 (ROC) 曲线分析被用来确定预测因素.
- 评估了基线临床和实验室数据,包括诊断的持续时间,网红细胞计数和血小板计数.
主要成果:
- 27周没有观察到完全反应;57.4%的患者出现了部分反应.
- 27周的罗米普洛斯蒂姆反应的重要预测因素包括诊断后的持续时间 (P=0.040),基线红细胞细胞计数 (P<0.001) 和基线血小板计数 (P<0.001).
- 在ROC分析中发现,预测响应的基线网细胞计数截止值为30.77 × 10^9/L (灵敏度:82.9%,特异性:73.1%).
结论:
- 从诊断的持续时间,基线线皮质细胞计数和基线血小板计数是罗米普洛斯蒂姆对耐火AA反应的显著预测因素.
- 一个特定的网细胞计数值可以帮助预测治疗疗效.
- 这些发现有助于为AA患者个性化TPO-RA治疗.
相关概念视频
Factors Affecting Drug Response: Overview
2.4K
When it comes to infants and young children, they are typically administered smaller doses of medication in comparison to adults. This is primarily because their organ functions still need to fully develop, meaning their bodies are not as efficient at metabolizing or eliminating drugs. Additionally, their blood-brain barrier is more permeable than in adults. As a result, high concentrations of drugs can easily penetrate the central nervous system (CNS), potentially leading to neurological...
2.4K
Bone Marrow Sampling and Transplants
506
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
506
Factors Affecting Protein-Drug Binding: Patient-Related Factors
119
Protein-drug binding, a pivotal aspect of pharmacokinetics, is subject to considerable variability influenced by an array of patient-related factors. The intricate interplay of age, individual differences, and pathological conditions significantly impact the binding dynamics and subsequent pharmacological effects.
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
Age stands as a key determinant in protein-drug binding. Neonates, characterized by low albumin content, experience heightened concentrations of unbound drugs such as phenytoin and...
119
Factors Affecting Erythropoiesis
3.7K
The cardiovascular system regulates the number of erythrocytes in the bloodstream to ensure optimal oxygen transport. It also prevents over-proliferation of these cells, which helps to maintain blood viscosity and flow rate.
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
Several factors influence the erythrocyte production rate, with tissue oxygen level being among the most critical. Intense exercise or high altitudes can cause tissue hypoxia, which triggers the kidneys to release more erythropoietin (EPO) into the bloodstream.
EPO then...
3.7K


